Company Filing History:
2 out of 186 
1 out of 832,843 Years Active: 2022-2024
Title: Christopher Ellison: Innovator in Genetic Assessment Technologies
Introduction
Christopher Ellison is a prominent inventor based in San Diego, CA, known for his contributions to the field of genetic assessment technologies. With a total of 3 patents, he has developed innovative methods that enhance the understanding of genetic alterations in non-invasive ways.
Latest Patents
Ellison's latest patents include groundbreaking technologies such as "Methods for Non-Invasive Assessment of Genetic Alterations." This patent outlines a method that involves obtaining a set of sequence reads, each containing a single molecule barcode (SMB) sequence. The process includes assigning these reads to groups based on a read group signature, which helps in determining the presence or absence of genetic alterations. Another significant patent is "Copy Number Alteration and Reference Genome Mapping," which focuses on assessing genomic nucleic acid stability and instability. This method utilizes genomic portions coupled with copy number alteration quantifications to evaluate the genetic condition of a subject.
Career Highlights
Throughout his career, Christopher Ellison has worked with notable companies, including Sequenom, Inc. His work has significantly impacted the field of genomics, particularly in non-invasive testing methods that provide critical insights into genetic health.
Collaborations
Ellison has collaborated with talented individuals such as Taylor Jacob Jensen and Youting Sun, contributing to the advancement of genetic assessment technologies.
Conclusion
Christopher Ellison's innovative work in genetic assessment technologies showcases his commitment to improving non-invasive testing methods. His patents reflect a significant advancement in understanding genetic alterations, making a lasting impact in the field of genomics.